Status:

COMPLETED

A Study of Embeda (Kadian NT, ALO-01) in Subjects With Pain Due to Osteoarthritis of the Hip or Knee

Lead Sponsor:

Pfizer

Conditions:

Osteoarthritis

Chronic Pain

Eligibility:

All Genders

21+ years

Phase:

PHASE3

Brief Summary

The purpose of this study is to evaluate the efficacy of Kadian NT (ALO-01) compared with placebo for treating moderate to severe chronic pain over a 12 week period.

Detailed Description

The primary objective of this study is to evaluate the efficacy of ALO-01 compared with placebo for the treatment of chronic moderate to severe pain (focusing on osteoarthritis of the hip or knee) as ...

Eligibility Criteria

Inclusion

  • Subject is 21 years of age or older
  • Subject is either not of childbearing potential OR subject must use an acceptable method of birth control if of childbearing potential
  • Negative pregnancy test if female of childbearing potential
  • Subject is in general good health
  • Subject required treatment of joint pain within the last 90 days
  • Subject has primary diagnosis of osteoarthritis (OA) of the hip or knee

Exclusion

  • Subject has a documented history of allergic reaction or intolerance to morphine or other opioids
  • Subject is pregnant or breast-feeding
  • Subject is receiving systemic chemotherapy
  • Subject has a history of drug abuse/dependence/misuse or alcohol abuse/dependence
  • Subject has history of major depressive disorder not controlled with medication
  • Subject has any chronic pain syndrome (i.e., fibromyalgia) that may interfere with the symptoms of OA
  • Subject has active gastrointestinal disease, with the exception of gastroesophageal reflux disease (GERD)
  • Subject has a documented history of rheumatoid arthritis, uncontrolled inflammatory arthritis or non-steroidal anti-inflammatory drug (NSAID)-dependent inflammatory arthritis

Key Trial Info

Start Date :

December 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2007

Estimated Enrollment :

547 Patients enrolled

Trial Details

Trial ID

NCT00420992

Start Date

December 1 2006

End Date

November 1 2007

Last Update

September 20 2013

Active Locations (81)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 21 (81 locations)

1

The Birmingham Pain Center

Birmingham, Alabama, United States, 35244

2

Horizon Research Group

Mobile, Alabama, United States, 36608

3

Arizona Center for Clinical Research

Peoria, Arizona, United States, 85383

4

Arizona Research Center, Inc

Phoenix, Arizona, United States, 85023